Clinical Trial Update: Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating a single dose of rosuvastatin with tipranavir/ritonavir in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Rosuvastatin (rosuvastatin)
• tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV Infections | Phase 1 | Status: COMPLETED